Geriatric assessment and treatment outcomes in a Dutch cohort of older patients with potentially curable esophageal cancer

References

• Uhlenhopp DJ, Then EO, Sunkara T, et al. Epidemiology of esophageal cancer: update in global trends, etiology and risk factors. Clin J Gastroenterol. 2020;13(6):1010–1021.
   PubMed Web of Science ®Google Scholar
• Lowsky DJ, Olshansky SJ, Bhattacharya J, et al. Heterogeneity in healthy aging. J Gerontol A Biol Sci Med Sci. 2014;69(6):640–649.
   PubMed Web of Science ®Google Scholar
• van Hagen P, Hulshof MC, van Lanschot JJ, et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med. 2012; 366(22):2074–2084.
   PubMed Web of Science ®Google Scholar
• Cloos VBM, Portier ESH, Fiocco M, et al. Neoadjuvant chemoradiotherapy followed by resection for esophageal cancer: clinical outcomes with the 'CROSS-regimen' in daily practice. Dis Esophagus. 2021; 23:doab068.
   Web of Science ®Google Scholar
• Munch S, Pigorsch SU, Devecka M, et al. Neoadjuvant versus definitive chemoradiation in patients with squamous cell carcinoma of the esophagus. Radiat Oncol. 2019;14(1):66.
   PubMed Web of Science ®Google Scholar
• Smit JK, Muijs CT, Burgerhof JG, et al. Survival after definitive (chemo) radiotherapy in esophageal cancer patients: a population-based study in the North-East Netherlands. Ann Surg Oncol. 2013;20(6):1985–1992.
   PubMed Web of Science ®Google Scholar
• Stahl M, Stuschke M, Lehmann N, et al. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol. 2005;23(10):2310–2317.
   PubMed Web of Science ®Google Scholar
• van Ruler MA, Peters FP, Slingerland M, et al. Clinical outcomes of definitive chemoradiotherapy using carboplatin and paclitaxel in esophageal cancer. Dis Esophagus. 2017;30(4):1–9.
   PubMed Web of Science ®Google Scholar
• Mantziari S, Teixeira Farinha H, Bouygues V, et al. Esophageal cancer in elderly patients, current treatment options and outcomes; a systematic review and pooled analysis. Cancers (Basel). 2021;13(9):2104.
   PubMed Web of Science ®Google Scholar
• van Abbema DL, van den Akker M, Janssen-Heijnen ML, et al. Patient- and tumor-related predictors of chemotherapy intolerance in older patients with cancer: a systematic review. J Geriatr Oncol. 2019;10(1):31–41.
   PubMed Web of Science ®Google Scholar
• van Deudekom FJ, Klop HG, Hartgrink HH, et al. Functional and cognitive impairment, social functioning, frailty and adverse health outcomes in older patients with esophageal cancer, a systematic review. J Geriatr Oncol. 2018;9(6):560–568.
   PubMed Web of Science ®Google Scholar
• Bellera CA, Rainfray M, Mathoulin-Pelissier S, et al. Screening older cancer patients: first evaluation of the G-8 geriatric screening tool. Ann Oncol. 2012;23(8):2166–2172.
   PubMed Web of Science ®Google Scholar
• Brooke P, Bullock R. Validation of a 6 item cognitive impairment test with a view to primary care usage. Int J Geriat Psychiatry. 1999;14(11):936–940.
   PubMed Web of Science ®Google Scholar
• van Holstein Y, van Deudekom FJ, Trompet S, et al. Design and rationale of a routine clinical care pathway and prospective cohort study in older patients needing intensive treatment. BMC Geriatr. 2021;21(1):29.
   PubMed Web of Science ®Google Scholar
• Guigoz Y, Lauque S, Vellas BJ. Identifying the elderly at risk for malnutrition. The mini nutritional assessment. Clin Geriatr Med. 2002;18(4):737–757.
   PubMed Web of Science ®Google Scholar
• Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383.
   PubMedGoogle Scholar
• Katz S, Ford AB, Moskowitz RW, et al. Studies of illness in the aged. The index of ADL: a standardized measure of biological and psychosocial function. JAMA. 1963;185:914–919.
   PubMed Web of Science ®Google Scholar
• Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 1969;9(3):179–186.
   PubMed Web of Science ®Google Scholar
• Wang X, Ge X, Wang X, et al. S-1-Based chemoradiotherapy followed by consolidation chemotherapy with S-1 in elderly patients with esophageal squamous cell carcinoma: a multicenter phase II Trial. Front Oncol. 2020;10:1499.
   PubMed Web of Science ®Google Scholar
• Centraal Bureau voor de Statistiek (CBS). Personen in institutionele huishoudens. Statline. https://opendata.cbs.nl/statline/-/CBS/nl/dataset/82887NED/table?dl=5FF4E. 2022.
   Google Scholar
• Cooper L, Dezube AR, De Leon LE, et al. Outcomes of trimodality CROSS regimen in older adults with locally advanced esophageal cancer. Eur J Surg Oncol. 2021; 47(10):2667–2674.
   PubMed Web of Science ®Google Scholar
• Xu C, Xi M, Moreno A, et al. Definitive chemoradiation therapy for esophageal cancer in the elderly: clinical outcomes for patients exceeding 80 years old. Int J Radiat Oncol Biol Phys. 2017;98(4):811–819.
   PubMed Web of Science ®Google Scholar
• Mak RH, Mamon HJ, Ryan DP, et al. Toxicity and outcomes after chemoradiation for esophageal cancer in patients age 75 or older. Dis Esophagus. 2010; 23(4):316–323.
   PubMed Web of Science ®Google Scholar
• Rahimy E, Koong A, Toesca D, et al. Outcomes and tolerability of definitive and preoperative chemoradiation in elderly patients with esophageal cancer: a retrospective institutional review. Adv Radiat Oncol. 2020;5(6):1188–1196.
   PubMedGoogle Scholar
• Zhao Q, Hu G, Xiao W, et al. Comparison of definitive chemoradiotherapy and radiotherapy alone in patients older than 75 years with locally advanced esophageal carcinoma: a retrospective cohort study. Medicine (Baltimore)). 2017;96(35):e7920.
   PubMed Web of Science ®Google Scholar
• Koeter M, van Putten M, Verhoeven RHA, et al. Definitive chemoradiation or surgery in elderly patients with potentially curable esophageal cancer in The Netherlands: a nationwide population-based study on patterns of care and survival. Acta Oncol. 2018;57(9):1192–1200.
   PubMed Web of Science ®Google Scholar
• Zhang X, Tang T, Pang L, et al. Malnutrition and overall survival in older adults with cancer: a systematic review and Meta-analysis. J Geriatr Oncol. 2019;10(6):874–883.
   PubMed Web of Science ®Google Scholar
• Takeuchi S, Ohtsu A, Doi T, et al. A retrospective study of definitive chemoradiotherapy for elderly patients with esophageal cancer. Am J Clin Oncol. 2007;30(6):607–611.
   PubMed Web of Science ®Google Scholar
• Tougeron D, Di Fiore F, Thureau S, et al. Safety and outcome of definitive chemoradiotherapy in elderly patients with oesophageal cancer. Br J Cancer. 2008;99(10):1586–1592.
   PubMed Web of Science ®Google Scholar
• Jingu K, Takahashi N, Murakami Y, et al. Is concurrent chemotherapy with radiotherapy for esophageal cancer beneficial in patients aged 80 years or older? Anticancer Res. 2019;39(8):4279–4283.
   PubMed Web of Science ®Google Scholar
• Walter F, Bockle D, Schmidt-Hegemann NS, et al. Clinical outcome of elderly patients (>/= 70 years) with esophageal cancer undergoing definitive or neoadjuvant radio(chemo)therapy: a retrospective single center analysis. Radiat Oncol. 2018; 13(1):93.
   PubMed Web of Science ®Google Scholar
• Huang C, Huang D, Zhu Y, et al. Comparison of a concurrent fluorouracil-based regimen and a taxane-based regimen combined with radiotherapy in elderly patients with esophageal squamous cell carcinoma. Transl Oncol. 2020;13(3):100736.
   PubMed Web of Science ®Google Scholar
• Kenis C, Baitar A, Decoster L, et al. The added value of geriatric screening and assessment for predicting overall survival in older patients with cancer. Cancer. 2018;124(18):3753–3763.
   PubMed Web of Science ®Google Scholar
• Li D, Sun CL, Kim H, et al. Geriatric assessment-driven intervention (GAIN) on chemotherapy-related toxic effects in older adults with cancer: a randomized clinical trial. JAMA Oncol. 2021;7(11):e214158.
   PubMed Web of Science ®Google Scholar
• Lund CM, Vistisen KK, Olsen AP, et al. The effect of geriatric intervention in frail older patients receiving chemotherapy for colorectal cancer: a randomised trial (GERICO). Br J Cancer. 2021;124(12):1949–1958.
   PubMed Web of Science ®Google Scholar
• Jolly TA, Deal AM, Nyrop KA, et al. Geriatric assessment-identified deficits in older cancer patients with normal performance status. Oncologist. 2015;20(4):379–385.
   PubMed Web of Science ®Google Scholar
• Wedding U, Kodding D, Pientka L, et al. Physicians' judgement and comprehensive geriatric assessment (CGA) select different patients as fit for chemotherapy. Crit Rev Oncol Hematol. 2007;64(1):1–9.
   PubMed Web of Science ®Google Scholar